Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-04-11
1986-12-16
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514428, 514597, 514629, 514913, A61K 31445, A61K 3140, A61K 3117, A61K 3116
Patent
active
046297308
ABSTRACT:
Elevated intraocular pressure diseases such as glaucoma are treated with compounds represented by formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof, wherein R.sub.1 is alkyl of two to four carbon atoms; and
REFERENCES:
patent: 2050557 (1936-08-01), Brokmuhl et al.
patent: 3644520 (1972-02-01), Hartley et al.
patent: 3689524 (1972-09-01), Jack et al.
patent: 3763232 (1973-10-01), Kaiser et al.
patent: 3803230 (1974-04-01), Jack et al.
patent: 3976783 (1976-08-01), Cox et al.
patent: 4127674 (1978-11-01), Leopold
patent: 4146645 (1979-03-01), Schromm et al.
patent: 4287211 (1981-09-01), Ferrari et al.
patent: 4404222 (1983-09-01), Baker et al.
patent: 4482566 (1984-11-01), Hirai et al.
patent: 4507320 (1985-03-01), De Marinis et al.
Remington's Pharmaceutical Sciences, 16th Ed., (Mack Pub. Co., 1980), Chapter 86, pp. 1498-1517.
T. Nogrady, "Medicinal Chemistry, A Biochemical Approach," Ch. 4.3-4.4, pp. 140-174 (Oxford University Press, 1985).
A. M. Barrett, Design of .beta.-Blocking Drugs in "Drug Design," vol. III, pp. 205-208 (Academic Press, 1972).
Clark Robin D.
Waterbury L. David
Green Grant D.
Krubiner Alan M.
Moran Tom M.
Robinson Douglas W.
Syntex (U.S.A.) Inc.
LandOfFree
Method for treating intraocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating intraocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating intraocular hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-245288